Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia
Clinical trial NCT00562328 · COMPLETED
Trial details
- NCT number
- NCT00562328
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-02-05
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.